Skip to main content

1366 (Emtricitabine and Tenofovir Disoproxil Fumarate 167 mg / 250 mg)

Pill with imprint 1366 is White, Capsule-shape and has been identified as Emtricitabine and Tenofovir Disoproxil Fumarate 167 mg / 250 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc.

Emtricitabine/tenofovir is used in the treatment of pre-exposure prophylaxis; occupational exposure; nonoccupational exposure; hiv infection and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Emtricitabine/tenofovir 167 mg / 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 1366

Emtricitabine and Tenofovir Disoproxil Fumarate

Imprint
1366
Strength
167 mg / 250 mg
Color
White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Antiviral combinations
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Zydus Pharmaceuticals (USA) Inc.
Manufacturer
Cadila Healthcare Limited
National Drug Code (NDC)
70710-1364

Get help with Imprint Code FAQs.

Related images for "1366"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.